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Comparative effect of ANF and various diuretics on isolated nephron
segments. The effect of the synthetic form of ANF 0.1 to 10 g/m1
(peptide 101-126), a diuretic and natriuretic peptide isolated from rat
heart atria, on the metabolism of dog and rat kidney tubules was studied
in vitro and compared to that of furosemide (0.1 to 1 mM),
hydrochlorothiazide (0.5 mM) or amiloride (0.1 mM). In order to
pinpoint eventual site(s) of ANF action along the nephron, proximal
tubules, thick ascending limbs and papillary collecting ducts were
isolated from dog kidneys as well as proximal tubules from rat kidneys.
The substrate uptake (02, lactate, glutamine, glucose) and production of
metabolites (glutamate, ammonium, alanine, glucose) by these nephron
segments were measured in absence or presence of the diuretic agents
or the vehicle for ANF (acetate 1 mM). The total ATP turnover and the
contribution of identified metabolic pathways for this turnover was
calculated. It was expected that a molecule with diuretic properties
reducing the permeability of cell membranes to NaCI would secondarily
reduce the Na-K-ATPase activity, and therefore the oxygen and
substrate utilization by affected cells. It was shown: 1) that each
nephron segment used presented the expected specific metabolic char-
acteristics; 2) that furosemide markedly inhibits the oxidative metabo-
lism of thick ascending limbs; 3) that acetate (the vehicle used for ANF)
displaces the oxidation of glutamine and lactate in nephron segments
with aerobic metabolism; 4) that ANF had no effect on the metabolism
of the studied segments despite the presence of specific c'GMP-
generating receptors in the distal nephron. It is concluded that ANF
must exert its natriuretic effect by a mechanism different from that of
classical diuretics.
The atrial natriuretic factors (ANFs) consist of a family of
peptides originating from mammalian heart atrias and present
strong natriuretic and diuretic properties [1]. The mechanism(s)
and site(s) of this effect along the nephron is not known. In vivo
studies in dogs and rats have suggested that both hemodynamic
changes alone [2, 31 and/or specific tubular interactions of ANF
with proximal [2, 4] or distal [5—7] segments of the nephron may
be responsible for the observed natriuresis.
The present study was therefore performed in vitro to deter-
mine if a biologically—active synthetic ANF (101-126) could
elicit a diuretic like effect on the metabolism of various seg-
ments of the nephron of the dog and on proximal tubules of the
rat. Since epithelial cells, like those of the nephron, use 80% or
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more of their ATP turnover to achieve ionic translocation [8], a
direct relation is observed between sodium transport, oxygen
consumption and substrate utilization by these cells both in
vivo [81 and in vitro [9]. The presence of a molecule that
interferes with the entry of sodium in the intracellular compart-
ment (diuretic—like effect) reduces the energy needs for sodium
translocation and therefore reduces both substrates and oxygen
uptake by the affected cells. We have compared the metabolic
effects of synthetic ANF and of various diuretics on renal
tubules obtained from dogs and rats. In an effort to identify
ANF-responsive segments along the dog nephron, suspensions
of glomeruli, proximal tubules, medullary thick ascending
limbs, and papillary collecting ducts were studied. Our results
demonstrate that ANF is devoid of a diuretic—like action on
renal metabolism in all segments examined in vitro.
Methods
Tubules suspension in the dog
All experiments were performed with kidneys of mongrel
dogs. The animals were fed a commercial diet (Purina Dog
Chow) and were deprived of food for 12 hours before the
experimental procedure. Following anesthesia with sodium
pentobarbital (30 mg/kg), the animals were intubated and con-
nected to a volume and rate adjustable respirator (Harvard
Apparatus Company, Milliss, Massachusetts, USA). Both
kidneys were rapidly removed and placed in ice—cold
Krebs—Henseleit saline. Each kidney was then cut in large
slices and the superficial cortex, the red inner medulla and the
white papilla were carefully dissected out with fine scissors.
Each tissue fraction was then sliced with a Stadie—Riggs
microtome and digested with collagenase for 45 minutes (cor-
tex) or 60 minutes (red medulla and papilla) as previously
described [10]. Lactate 10 m and glucose 10 m were added in
the flasks during the digestion procedure of medullary or
papillary tissue, respectively.
Proximal tubules
The suspension of tissue elements obtained following diges-
tion of slices from the renal cortex was then seived (120 m
mesh) to remove the glomeruli (a pure suspension of dog
glomeruli is obtained as a by product) and the tubular structures
were resuspended in isoosmotic Percoll as described for the rat
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tissue [10]. Following centrifugation, the proximal tubules are
separated in the density gradient as a single lower band from the
lighter upper bands containing mixtures of distal structures,
isolated cells, and shorter segments of proximal tissue. The
proximal fraction was collected, washed and a final suspension
containing around 60 mg wet weight of proximal tubules per ml
was obtained. As for the rat [10], the proximal origin of the dog
tubules was confirmed by the presence of brush borders by
optical and electronic microscopy, as well as by specific func-
tional characteristics of this tissue (rapid respiration, rapid
glutamine metabolism, rapid gluconeogenesis, specific popula-
tion of enzymes and receptors to hormones with predominant
proximal effect such as parathormone).
Thick ascending limbs
The tubules obtained from the red medulla contained pre-
dominantly thick ascending limbs contaminated with a small
fraction of collecting ducts (less than 10%). This preparation
was similar to that obtained by Baverel, Forissier and Pellet [11]
using dog and by Chamberlin, Lefurgey and Mandel using
rabbit kidney [12], Around 0.5 g wet weight of tubules was
obtained from both kidneys of a dog. Functionally, this tissue
presented a rapid respiration, poor glutamine but rapid lactate
metabolism, absence of gluconeogenic capacity and selective
sensitivity to furosemide (0.1 mM).
Papillary collecting ducts
The tubules similarly isolated from the papillary regions
formed a white suspension containing 0.2 g wet weight of
collecting ducts with typical morphology (optic and EM) and
physiological characteristics (anaerobic metabolism, rapid
glycolysis, receptors to antidiuretic hormone).
Thus four purified renal fractions are obtained from the two
kidneys of one dog: 1) glomeruli; 2) proximal tubules; 3) thick
ascending limbs and 4) papillary collecting ducts. The metabolic
utilization of substrates by the tissue of each fraction was
shown to be linearly related to time for more than 120 minutes.
For collecting ducts, a similar rate of glucose utilization was
observed when the tubules were incubated in aerobic or
anaerobic conditions.
Tubules suspension in the rat
A suspension of rat proximal tubules was also obtained as
described above using a method established in our laboratory
[10]. Because of the limited amount of medullary or papillary
tissue available with rat kidneys, no attempt was done to obtain
thick ascending limbs or papillary collecting ducts from this
species.
Incubation procedure and metabolites measurements
Around 30 mg wet weight of proximal and thick ascending
limbs or 15 mg of collecting ducts were incubated in 4 ml gassed
(95% 02, 5%C02) Krebs—Henseleit saline and placed in silicon-
ized flasks as reported previously [10]. Albumin was omitted in
all experiments. The following substrates were used: 1) for
proximal tubules: a mixture of lactate 2 mrvi + pyruvate 0.2 mM
(physiological lactate/pyruvate ratio) with glutamine 2 mM +
glutamate 0.2 m. This substrate mixture was chosen because
the totality of the ATP turnover in proximal tubules of dogs and
rats is accounted for by the removal and metabolism of these
substrates in combination [13]. 2) The same conditions were
used for the study of thick ascending limbs. 3) Collecting ducts
were incubated aerobically in presence of glucose 1 or 2 mM. In
all three tissues, the following conditions were superimposed:
1) control; 2) furosemide 0.1 mM; 3) furosemide 1 mM; 4)
amiloride 0.1 mM; 5) hydrochlorothiazide 1 mM; 6) acetate 2.5
m (vehicle of ANF); 7) acetate 2.5 m + ANF (101-126) 2
tgImI; 8) acetate 2.5 mtvi + ANF (101-126) 2 igIml + 1-methyl-
3-isobutylxanthine (MIX) 0.5 m and 9) MIX 0.5 m alone.
MIX is an inhibitor of phosphodiesterases and was used in
order to magnify an eventual effect of ANF mediated by the
local production of cyclic nucleotides. The tissue was incubated
for 30 (rat) or 60 (dog) minutes at 37°C. At the end of the
incubation procedure, the flasks were deproteinized with
perchloric acid (final concentration 10 g/dl) and glutamine,
lactate, glutamate, alanine, glucose and ammonium were mea-
sured by enzymatic techniques on a neutralized sample as
previously reported [10]. Separate flasks were deproteinized at
time 0 to measure the initial concentrations of relevant metab-
olites.
Oxygen consumption measurements
The oxygen consumption by the tubules was measured
polarographically in a specially—designed oxymetric chamber
[14]. A short, five—minute preincubation procedure was used to
heat up the tubules to 37°C before their introduction in the
oxymetric chamber containing fresh incubation medium and the
appropriate concentration of substrates. An aliquot (0.5 ml) of
the tubules suspension was introduced in the oxymetric cham-
ber (2.7 ml) thermostated at 37°C and the change in P02 was
followed for 0 to 15 minutes [13]. Following a control period (5
mm), the experimental conditions described above were repro-
duced within the oxymetric chamber by introducing the various
effectors studied (in a final volume of 10 to 100 1d). Therefore
the effect of all effectors was assessed by comparing the
respiration of the same tubules before and after their addition.
Sham additions were included in the protocol (no effector) to
demonstrate that 02 consumption is linear with time (until very
low P02 are observed, that js, for around 30 to 35 mm) and is
not modified by the injection procedure. Since the oxymetric
measurements were performed sequentially in the same cham-
ber, the order of the effectors tested was randomized to avoid
introducing a bias by the waiting time of fresh tubules on ice in
gassed Krebs—Henseleit saline.
The metabolic data obtained in flasks after 30 or 60 minutes of
incubation were therefore compared to the oxygen consump-
tion data obtained from the same tubules suspension, but after
only 10 to 15 minute incubation periods. It was previously
shown that oxygen consumption by cortical tubules proceeds
linearly for more than one hour when followed in a Warburg
apparatus [15]. It was accepted that for all tissues studied the
rate observed over 10 to 15 minutes was representative of the
respiration process occurring for up to one hour in tissue
incubated in flasks.
Stability of ANF in suspensions of nephron segments
In order to investigate the stability of ANF (101-126) in these
suspensions of nephron segments, two maneuvers were per-
formed: first, the diuretic activity of 500 pi incubation fluid
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Table 1. Effect of diuretics and ANF on the metabolism or proximal tubules of dog kidney in vitro
Incubation conditions
Control
MIX
0.5 mri
.Furosemide
0.1 mMMetabolites production (+) or uptake (—)
02 -253 28 —316 28 —225 41
Glutamine
—58 5.2 —59 5.0 —59 6.2
Lactate -107 7.4 —116 10.4 —101 3.9
Glutamate 29 5.7 32 4.6 29 5.7
Alanine 31 2.1 27 1.9 28 2.0
Glucose 26 1.5 24 1.2 24 0.3
NH4 70 6.1 75 5.2 69 5.8
ATP produced through substrates metabolism
Glutamine to OAA-GLDH (12 ATP) 60 96 78
Glutamine to transamination (9 ATP) 279 243 252
Lactate to pyruvate (3 ATP) 321 348 303
OAA/pyruvate to CO2 (15 ATP) 900 1140 893
Sum of ATP produced 1560 1827 1526
ATP turnover from 02 uptake 1518 1896 1350
ATP produced from identified metabolic pathways 102.8% 96.3% 113.0%
The amount of substrates produced or utilized are expressed per g of fresh wet weight and per hour (N = 5). The various metabolic pathways
were identified and the ATP produced by each of them was calculated using the following relations: glutamine to glutamate = glutamine uptake (0
ATP); glutamate to oxaloacetate through glutamate deamination (GLDH) = ammonia balance/2 (12 ATP); glutamate to OAA through
transamination = alanine synthesis (9 ATP); lactate to pyruvate = lactate uptake (3 ATP); pyruvate to the oxaloacetate/pyruvate pool = lactate —
alanine (0 ATP); OAA/pyruvate to CO2 = total oxaloacetate/pyruvate (from glutamine and lactate) — glucose x 2 (15 ATP). The sum of the ATP
produced by these processes was compared to the total ATP turnover as estimated from 02 uptake (assuming 6 ATP produced per 02 consumed).
(centrifuged to obtain a clear supernatant) of tissue segments
incubated for 15 minutes with ANF (101-126, 2 jsg/ml) or with
its vehicle was compared to that of 500 pi of fresh solution of
ANF (2 g/ml) dissolved in Krebs—Henseleit saline. In separate
flasks, a cocktail of proteases inhibitors establishing a final
concentration of bacitracin, 0.7 mM; phenylmethylsulfonyl flu-
oride, 0.5 mM; aprotinin 1 mM; and soybean trypsin inhibitor,
1.6 mglml was added in order to protect ANF from destruction
by tissue proteases. For this biological assay, rats were anes-
thetized, placed in a heated cabinet, and the left jugular vein
and bladder were catheterized. The animals were infused at 1.0
mllhr with freshly gassed, Krebs—Henseleit saline during a 30
minute control period and three 10 minute urine samples were
collected in preweighted microtubes. The infusion was then
switched for the tested fluid infused at the same speed, and the
urine was collected for one or two additional periods. The
urinary volume as well as the rate of excretion of urinary
sodium and potassium were measured.
The stability of ANF (101-126) was also investigated by
following the recovery of radio-iodinated ANF (125J) from the
incubation medium of each tissue suspensions following a short
(5 mm) or longer (30 mm) incubation with ANF (2 ig/m1) with
or without the cocktail of proteases inhibitors described above.
Samples of the incubation fluid (100 d) were collected, acidified
with four volumes of glacial acetic acid and analyzed by HPLC.
The HPLC system used a uBondapak C-l8 column, and two
buffers (A and B) which were mixed in order to obtain a
progressive hydrophobic gradient from 15% to 55% (1%/mm)
and a total flow of 1 mllmin. Buffer A was a solution of
trifluoroacetic acid (0.1 g/dl) in water while buffer B was a
solution of trifluoroacetic acid (0.1 g/dl) in acetonitrile. Forty
successive 1 ml aliquots were collected after injection of the
sample. Intact '251-ANF as well as '251-ANF obtained from
control flasks eluted as a single peak at 24 to 25 minutes.
Additional studies
Time course studies were the production of glucose from
lactate (2 mM), glutamine (2 mM), or malate (2 mM), were also
performed using short incubation times (0, 2, 4, 8, 12 mm). In
these experiments, the vehicle for ANF (acetate 2.5 mM) was
placed in control flasks while synthetic natriuretic peptides of
different lengths (101-126, as well as 103-126 and 105-126 in two
experiments) were placed in equimolar quantities in experimen-
tal flasks. These experiments were performed with or without
the presence of the inhibitors of proteases activity in the
incubation medium. In parallel flasks, the effect of c'GMP or 8
bromo c'GMP (3 x l0" M) on an eventual metabolic effect of
ANF was studied.
Calculations
The metabolic pathways used for lactate or glutamine metab-
olism was estimated as explained below and the ATP produced
at each step calculated [13, 15]. The glutamine extracted was
assumed to be first deamidated into glutamate (0 ATP). This
glutamate accumulates as such (0 ATP), or is transformed into
oxaloacetate through the glutamate dehydrogenase (GLDH),
deamination pathway (12 ATP), or the transamination pathway
(9 ATP). An ammonia balance allows to estimate the amount of
glutamate metabolized using the GLDH pathway while the
accumulation of transamination products (alanine, aspartate)
quantifies the second process. No aspartate synthesis was
observed in our incubation conditions.
The lactate taken up must be first transformed into pyruvate
(3 ATP) which may in turn enter the transamination pathway to
form alanine (0 ATP), or join the oxaloacetate/pyruvate pool
already enriched by carbon skeletons from glutamine. The
molecules of this pool can be oxidized to CO2 (15 ATP) or may
enter the glucose synthesis pathway (0 ATP) in gluconeogenic
tissue (proximal tubules). The latter process can be estimated
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Table 1. Continued
Furosemide
1 mM
Amiloride
0.1 mj
Thiazide
1 mM
Acetate
2.5 mrvi
ANF
2 tg/m1
ANF 2 gIm
MIX 0.5 mM
—194 40 —252 25
—255 31 —222 31 —222 25 —223 24
—55 6.7 —60 10.0
—70 8.0 —54 4.6 —58 5.0 —54 8.5
—90 8.1 —105 11.9
—102 7.6 —56 3.9 —56 3.2 —52 6.7
27 4.5 33 4.4 32 4.3 41 6.8 44 3.7 44 4.3
28± 1.9 27± 1.8 35 15± 1.5 14± 1.2 13± 1.222 0.8 21 1.5 24 2.4 18 2.0 17 1.8 15 1.867 5.0 61 3.7 69 5.2 65 5.1 69 6.6 65 4.5
72 6 12 54 66 48
252 243 315 135 126 117
270 315 306 168 168 156
780 953 825 368 413 390
1374 1517 1458 724 773 711
1164 1512 1530 1332 1332 1338
118.0% 100.3% 95.3% 54.4% 58.0% 53.1%
from glucose production (2 oxaloacetate for 1 glucose). The
sum of the ATP produced by each of these processes was
calculated as compared to the total ATP turnover estimated
from oxygen uptake (6 ATP per 02). For anaerobic papillary
tissue, the glycolytic flux was directly estimated from glucose
disappearance.
Statistical analysis
The data are presented as means SEM with n indicating the
number of different tubules preparations studied. The effects of
furosemide, amiloride, hydrochlorothiazide and acetate were
contrasted with the control situation, and that of ANF with or
without MIX by comparison with acetate alone (the vehicle for
ANF) using variance analysis for repeated measurements. A
value of P smaller than 0.05 was considered significant.
Results
Metabolism of proximal tubules of the dog
Table 1 presents the uptake and production of metabolites
following a 60 minute incubation of dog proximal tubules.
Clearly, in presence of glutamine plus lactate, this tissue
respires at a fast speed (253 tmolIhr), and is strongly
gluconeogenic and ammoniagenic as expected for proximal
tubules [10, 13]. The analysis presented in Table 1 shows that
from the 58 mol of glutamate produced from glutamine uptake,
29 is accumulated as such while the remaining 29 are metabo-
lized to alpha-ketoglutarate using the transamination pathway
with pyruvate, explaining nearly all the 31 tmol of alanine
accumulating during the incubation. The aipha-ketoglutarate
produced following transamination (29 moles) is then further
metabolized to oxaloacetate/pyruvate which can enter either in
the gluconeogenic or the oxidative pathways. The pyruvate
formed from the lactate extracted (107 jimol) in part generates
alanine (31 tmol) while the rest (76 mol) enters the common
oxaloacetate/pyruvate pool. From this pool, 52 mol are trans-
formed into glucose (2 oxaloacetate/pyruvate per glucose
formed) and the rest (58 imol) is assumed to be oxidized. The
ammonia balance indicates however that 5 tmol of glutamine
are also transformed into OAA. Indeed, from the ammonia
produced (70 mol) only 60 mol are attributable to glutamate
and alanine accumulation. This leaves 10 mol of ammonia not
explained by aminoacids synthesis from glutamine. If this
ammonia comes from glutamine, a maximum of 5 tmo1 of
glutamine was metabolized to OAA by the glutamate dehydrog-
enase pathway and joined the OAAlpyruvate pool. This small
contribution of the GLDH pathway was not detected with the
carbon balance. Since glutamine extraction is not measured as
precisely (subtraction of two large numbers) than NH4 accumu-
lation, the ammonia balance was preferred over the carbon
balance in estimating the metabolic fates of glutamine, and the
oxaloacetate/pyruvate pool was considered enriched by 5 imol.
The total ATP generated by these pathways is 1560 jmol per
g' . h, a value close to 1518 imo1 calculated from oxygen
uptake. Thus in the control situation, the totality of the ATP
turnover in proximal tubules can be accounted for by the
observed metabolism of glutamine plus lactate. MIX alone does
not change this metabolism (Table 1).
When furosemide (0.1 and 1 mM) is added to the incubation
medium of proximal tubules a small inhibition (20%) of tissue
respiration is noted (Fig. 1). Simultaneously a small depression
of lactate metabolism (16%) by proximal tubules (Table 1) is
noted. Glutamine extraction remains unchanged. No effect of
amiloride (0.1 mM) or hydrochiorothiazide (1 mM) can be
observed.
When synthetic ANF (101-126) is added to the incubation
medium with or without MIX, the effect observed is identical to
that of its vehicle alone, that is, 2.5 mt acetate. The rapid
metabolism of this substrate does not affect significantly the
uptake of glutamine but operates a redistribution in the meta-
Dog proximal tubules Dog thick ascending limbs
Fig. 1. Dose response curve of the effect of ANF (0.1 to 10 jig/mI) and furosemide (0.011 mM) on oxygen uptake by proximal tubules (A) or thick
ascending limbs (B) isolated from the dog kidney. Data are given as percent of the respiration observed in absence of effector used (% of respiratory
activity). The effect of vehicle for ANF alone (2.5 m acetic acid) is illustrated at the right of the figure. Numbers indicate the number of different
tubule preparations where the condition was tested. Symbols are: A, (0) ANF, (•) furosemide, and (0) vehicle, in A, and B, (A) ANF, (A)
furosemide and (0) vehicle in B.
Table 2. Effect of ANF (101-126) with or without c'GMP on glucose production by kidney tubules studied with short incubation times
Number of
measurements
Acetate
m
2.5 Acetate +
ANF(s)
Acetate +
c'GMP
105M
Acetate +
ANF(s) +
c'GMP
Dog proximal tubules
Substrate
Lactate 2 mti 8 16.5 1.3 17.4 1.0 16.5 0.6 17.7 1.6
Malate 2 mti 4 17.0 1.4 18.1 1.3 20.9 0.5 23.1 1.0
Rat proximal tubules
Lactate 2 mrt 8 28.72 3.6 30.2 2.9 29.3 3.6 29.6 2.2
Malate 2 msi 4 21.9 2.9 21.6 3.0 18.6 3.9 20.2 1.9
Data are jsmol/g h (mean SEM). The glucose production was measured using short (2, 4, 6, 8, 12 mm) time courses in both species.
ANF(s) refers to experiments performed with the synthetic peptide 101-126, but also with 103-126 and 105-126 (two experiments with each species).
Data with all ANF(s) were not different and were therefore pooled. The c'GMP used was either natural c'GMP or 8-bromo-c'GMP (10-s M).
Identical results were found when lactate (2 mM) replaced acetate as vehicle for ANF (101-126).
bolic fate of this aminoacid in favor of glutamate accumulation.
This is a well known effect of short chain fatty acids on renal
glutamine metabolism in vitro in this species [16]. Lactate
extraction is significantly depressed however as well as alanine
production. This latter effect is probably attributable to the fast
generation of reducing equivalents from acetate oxidation,
reducing the cytoplasmic redox state and therefore diminishing
the free pyruvate concentration [17—19]. This effect probably
explains also the small anti-gluconeogenic effect of acetate, by
a reduction of oxaloacetate, the substrate of the PEPCK
reaction, into malate, However the inhibition of lactate extrac-
tion cannot be totally explained by the reduced transamination
and gluconeogenesis, indicating that an inhibition of oxaloace-
tate/pyruvate oxidation has also occurred. Indeed, the ATP
production calculated from substrate uptake is now only 50% of
that calculated from the tubular respiration. This indicates that
acetate oxidation has displaced a significant fraction of the
pyruvate previously oxidized. Thus acetate may be regarded as
a good substrate for proximal tubules metabolism.
From these observations it can be concluded: 1) that a
suspension of dog proximal tubules in vitro metabolizes
glutamine and lactate at a fast speed; 2) that these substrates are
able to support the totality of the tissue ATP turnover as
estimated from oxygen consumption; 3) that a fast gluconeo-
genic process is observed with these substrates as expected
from proximal tissue; 4) that acetate is able to displace pyruvate
oxidation in a significant fashion; 5) that furosemide has a small
but significant effect on proximal tubules metabolism and res-
piration; and 6) that synthetic ANF has no significant effect on
these processes.
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Additional experiments with dog proximal tubules
In additional experiments with proximal tubules, the effects
of three natriuretic peptides: ANFs 101-126, 103-126 and
105-126 as well as their vehicle (acetate 2.5 m or lactate 2 mM)
were studied using short time—course protocols and lactate or
malate (2 mM) as substrate. Glucose production was not signif-
icantly modified by the natriuretic peptides tested (Table 2).
The addition of various inhibitors of proteases (individually or
simultaneously) did not allow to observe a specific effect of
ANF (101-126) (not shown). The effect of c'GMP or 8-bromo
c'GMP (l0- M) on gluconeogenesis with or without ANF was
also followed: no significant effect of these cyclic nucleotides
could be detected, and their addition to the ANF(s) did not
disclose a stimulating effect of this peptide on the rate of
glucose synthesis.
Metabolism of thick ascending limbs of the dog
Table 3 presents the metabolism of thick ascending limbs
studied in similar conditions. Again a fast respiration of the
tissue is observed. However, in contrast to proximal tubules,
glutamine is poorly utilized while no glucose production is seen,
confirming the absence of the gluconeogenic machinery from
this distal segment of the dog nephron. The totality of the
glutamine uptake is accounted for by glutamate and alanine
accumulations. However, these two processes are of small
amplitude in comparison to what is observed with proximal
tissue. Since a similar amount of lactate and pyruvate was
provided to this tissue and since the synthesis of alanine occurs
through the near equilibrium alanine—aminotransferase system
according to the availability of the substrates of this reaction
(pyruvate, glutamate) and assuming a good permeability of
tubules membranes to lactate and glutamine, it may be con-
cluded that glutamate availability limits the formation of alanine
with this tissue. This indicates that glutamine does not generate
glutamate as fast as in proximal tissue, due to either a lower
permeability of the mitochondrial membrane to glutamine or a
lower glutaminase activity inside the mitochondrial compart-
ment. The ammonia balance discloses that only 3.5 mol of
glutamine are metabolized to CO2 through the GLDH pathway
while 6 imol is oxidized using the transamination pathway. In
accord, the ammoniagenesis is significantly smaller than that
observed with proximal tubules.
With ascending limbs, the major exogeneous substrate uti-
lized is lactate. However, only 66% of the total ATP turnover
can be accounted for by the removal of measured substrates
indicating that some endogenous non-ammoniagenic substrates
must also contribute to the metabolism of these tubules. Endog-
enous fatty acids oxidation is probably responsible for this
observation. Again identical observations are made in presence
of MIX.
When furosemide is added to this thick ascending limbs
suspension, a marked depression of oxygen uptake is observed
(Fig. 1). With 1 mi furosemide, this process is depressed by
68% (Table 3) indicating that the exquisite sensitivity of this
nephron segment to furosemide is conserved in vitro. This
response is similar to that described by Chamberlin, Lefurgey
and Mandel for a suspension of thick ascending limbs from
rabbit kidney [121 and slightly less than the comparable depres-
sion of respiration induced by ouabain (1 mM) (60%) (results not
shown). Simultaneously, the extraction of lactate is signifi-
cantly decreased while that of glutamine remains unchanged.
Now 84% of the ATP turnover calculated from oxygen uptake
can be explained by glutamine and lactate metabolism. Thus,
the inhibition of membrane permeability to chloride and sodium
induced by furosemide has drastically reduced the amount of
work performed by these structures, that is the Na-K-ATPase
activity, an effect immediately followed by a reduction in
substrate oxidation. This effect corresponds to the specific
diuretic property of furosemide since it can be completely
blunted when furosemide is prevented to enter the lumen of
these tubular segments (where the receptors of furosemide are
located, results not shown). Amiloride and hydrochlorothiazide
exert a qualitatively similar but only modest effect on the
metabolism of these structures.
The addition of acetate alone significantly inhibits lactate
uptake and oxidation. Again a large fraction of the ATP
turnover must be attributed to acetate oxidation. As in proximal
tubules, alanine synthesis is slightly decreased by acetate. The
presence of ANF (2 g/ml) or ANF plus MIX does not elicit
effects different from that of acetate alone.
It can be concluded: 1) that this tissue has the metabolic
characteristics of thick ascending limbs, that is, rapid respira-
tion, absence of gluconeogenesis and preferential metabolism of
lactate (as compared to glutamine); 2) that furosemide influ-
ences markedly the respiration and metabolism of this nephron
segment; 3) that acetate is an excellent substrate for this
nephron segment as already shown by Baverel, Forissier and
Pellet [11]; 4) that ANF has no specific metabolic effect on this
tissue. It is therefore clear that ANF exerts a diuretic effect on
the kidney by a mechanism different from that of furosemide.
Metabolism of collecting ducts in the dog
Table 4 shows that the collecting ducts obtained from papil-
lary tissue are largely anaerobic structures. A rapid utilization
of glucose is observed, accompanied by a significant accumu-
lation of lactate, indicating a major glycolytic process. The ratio
of glucose taken up to lactate produced is around 1.5 to 1.8
indicating that a small amount of the lactate produced is
metabolized further (transaminated into alanine or oxidized) in
aerobic conditions. No effect of furosemide, acetate, ANF,
thiazide, or amiloride could be demonstrated on this glycolytic
process nor on the accumulation of lactate.
With dog tissue, ANF was tested at concentration as high as
10 g/ml without disclosing an effect in vitro. In order to
directly check that the ANF molecule does not require a
transformation in the proximal nephron to be active on distal
sites, a preincubation (5 to 15 mm) of ANF with proximal
tubules was performed as well as coincubation of a mixture of
proximals + thick ascending limbs with ANF: none of these
maneuvres was successful in disclosing a metabolic effect to
ANF.
Metabolism of proximal tubules from rat kidneys
Similar data were obtained with rat kidney proximal tubules:
the control oxygen uptake of 274 7.3 mol g1 hr' (N =
25) was not changed by ANF (0.1 to 10 jsg/ml) (269 7.9jsg/ml g' hr', N = 13) nor by its vehicle (acetate or lactate
2.5 mM) (269 8.2 imol g1 hr', N = 18). In contrast,
ouabain, vanadate or ouabain plus vanadate significantly de-
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Table 3. Effect of diuretics and ANF on the metabolism of thick ascending limbs of dog kidney in vitro
Incubation conditions
Control
MIX
0.5 mM
.
Furosemide
0.1 mMMetabolites production (+) or uptake (—)
02 —316 22 —316 22 —166 30
Glutamine —18 1.8 22 3.3 —15 1.8
Lactate —61 5.7 —63 6.5 —37 5.3
Glutamate 8 0.8 8 1.0 8 0.8
Alanine 6 0.7 5 0.8 4 0.9
Glucose —1 0,5 —l 0.8 —1 0.7
NH4 21 1.9 21 2.3 19 2.8
ATP produced through substrates metabolism
Glutamine to OAA-GLDH (12 ATP) 42 48 42
Glutamine to OAA-transamination (9 ATP) 54 45 36
Lactate to pyruvate (3 ATP) 183 189 111
OAA/pyruvate to CO2 (15 ATP) 968 1005 608
Sum of ATP produced 1247 1287 797
ATP turnover from 02 uptake 1896 1896 996
ATP produced from identified metabolic pathways 65.7% 67.9% 79.9%
The amount of substrates produced or utilized are expressed per g of fresh wet weight and per hour (N = 7).The ATP produced during the metab-
olism of glutamine and lactate was calculated as following; glutamine to oxaloacetate (OAA) (GLDH) = ammonia balance % 2 x 15; glutamine to
OAA (transamination) = alanine production x 9; oxaloacetate to CO2 = OAA x 15; lactate to pyruvate = lactate uptake X 3; pyruvate to CO2
lactate uptake — alanine production x 15. The sum of the ATP produced by these processes was compared to the total ATP turnover as estimated
from 02 uptake (assuming 6 ATP produced per 02 consumed).
pressed the oxygen consumption by this tissue (Fig. 2). No
specific effect of ANF could be demonstrated on substrate
uptake or metabolites production (glucose, ammonium): all
observed changes were due to the vehicle used as in the dog
kidney.
Experiments using short incubation times and three natri-
uretic peptides were also performed using the protocols de-
scribed above for dog proximal tubules. No significant effect of
ANF on renal gluconeogenesis was found (Table 2).
Stability of ANF incubated with tissue suspensions
In order to verify that synthetic ANF remains active follow-
ing incubation with the renal tubules, the incubation fluid of
tissue incubated with ANF 2 /.Lg/ml for 15 minutes was injected
into bioassay rats: the injection of the supernatant of ANF-
containing flasks did not increase the urinary volume excretion
(control infusion 11.9 2.3; supernatant infusion 9.2 1.48,
jzl/min N = 9) a change similar to that observed when injecting
a sample obtained from flasks incubated with acetate alone
(control: 7.78 1.05; supernatant 6.22 0.97 4'min). In
contrast, when 1 tg fresh ANF (101-126) was administered to
the rats, the urinary excretion rate rose fivefold from 10.4
1.75 to 56.1 5.34 1.d/min. Only when a cocktail of proteases
inhibitors was present in the flasks, an infusion of ANF-
containing supernatant elicited an immediate twofold diuretic
(and natriuretic) response. This response was significantly
smaller than that elicited by injection of fresh ANF. These
observations suggest that ANF is gradually destroyed in the
incubation fluid of nephron segments, and that this process can
be reduced by the inhibitors used but not completely prevented.
To obtain a more direct evidence of the lack of stability of
ANF when incubated with tissue fragments, the recovery of
radio—iodinated ANF (2 p.g/ml) from the supematant of tubules
incubated for five or 30 minutes was studied. When a 30 minutes
incubation time was used, no radioactivity was recovered as
ANF in the incubation fluid. With a five minute incubation,
roughly one—third of ANF was recovered as such in the
supernatant of the various tissue fractions used. This recovery
rose to 70% when proteases inhibitors were present.
Thus, in absence of proteases inhibitors, ANF is destroyed in
less than 15 minutes with our preparation. In presence of
inhibitors, the half—life of ANF is prolonged. This destruction of
ANF was observed even when the peptide was incubated in
incubation fluid centrifuged at 100,000 x g for 60 minutes (4°C)
in order to remove tissue and membranes vesicles indicating
that the proteolytic enzymes responsible for this destruction
were soluble. These results also indicate that a significant
amount of ANF remains intact for around five minutes in the
incubation medium. This time may be longer when higher
concentration of ANF is used. Since oxygen uptake, the critical
parameter allowing to calculate the diuretic—sensitive ATP
turnover in these experiments, was followed continuously for 0
to 15 minutes after the addition of 0.5 to 10 g/ml ANF in the
oxymetric chamber, the lack of immediate effect of ANF cannot
be attributed to the rapid disappearance of the active peptide
from the incubation medium.
Discussion
The atrial natriuretic factors (ANFs) are a family of peptides
isolated from specific granules [1] predominantely located in the
right atria of the heart of all mammalian species examined [18].
The number of these granules was shown to change with the
status of water or sodium balance [19]. When the proteic
content of these granules is extracted and injected into bioassay
rats, a prompt diuresis and natriuresis is observed [20, 21]. The
active material has been purified and its aminoacid sequence
determined [221. Several peptides of various lengths were
observed originating from a common large propeptide of 73
aminoacids [22, 23]. In the rat, all these peptides share a
common 17-residue disulfide—bonded core. Several synthetic
peptides have been synthetized. We have used mainly a 26-
aminoacids synthetic form of ANF (101-126) for the present
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Table 3. Continued
Acetate Acetate
Fui-osemide Amiloride Thiazide Acetate + ANF + ANF
1 mM 0.1 mM 1 mM 2.5 mM 2 tgIm1 + MIX
—100 8
—252 18
—271 19 —315 21 —316 26 —316 22
—18 3.3
—22 3.9
—26 3.8 —19 1.2 —18 2.2 —17 3.3
—23 7.1
—73 4.3
—65 4.1 —25 5.6 —23 5.6 —31 3.4
6 1.6 8 0.4 8 1.3 10 1.2 11 1.0 11 1.15±0.8 5±0.6 5±0.5 3±0.4 3±0.5 3±0.5
—1 0.7
—2 0.9
—1 0.8 —1 0.2 —1 0.4 —2 0.8
15 2.6 20 2.5 20 2.8 17 1.2 17 1.3 16 2.4
24 42 42 24 18 12
45 45 45 27 27 27
69 219 195 75 69 93
375 1148 1028 405 368 480
513 1454 1310 53l 482 612
600 1512 1626 1890 1896 1896
85.5% 96.9% 80.5% 28.0% 25.4% 32.3%
Table 4. Effect of diuretics and ANF on the metabolism of papillary collecting ducts of dog kidney in vitro
Incubation
conditions
Metabolites Acetate Acetate
production (+) MIX Furosemide Furosemide Amiloride Thiazide Acetate + ANF + ANF
or uptake (—) Control 0.5 mri 0.1 mti 1 mr'i 0.1 mri 0.1 mvi 2.5mM 2 sg/ml + MIX
02 —39 8.4 —30 8.0 —16 10.1 —31 9.1 —31.7 8.8 —27.7 6.1 —45 12 —24 7.2 NM
Glutamine —105 5.2 —102 2.2 —109 5.4 —123 12 —99 7.1 —118 9 —110 13 —110 Il —110 33
Lactate 158 14 117 2 159 6.5 141 49 134 15 150 6 157 8 157 8 118 13
The amount of substrates produced or utilized are expressed per g of fresh wet weight and per hour (N = 5).
study, but some experiments were also performed with 103-126
and 105-126 peptides.
The intravenous administration of atrial extracts induces a
diuresis and natriuresis of rapid onset (1 or 2 mm) but short
duration (less than 20 mm) in various species (rat, dog, hamster,
mouse, monkey, man) [1, 19]. The 101-126 synthetic peptide
was found similarly active in vivo in dogs [24] and rats [251. The
mechanism of this effect remains controversial. In recent pa-
pers a significant increment in GFR was noted in rats [71 and
dogs [2, 26, 27] as well as in isolated perfused rat kidney [3, 28,
291. However, in several reports, the natriuretic effect observed
could not be solely attributed to changes in GFR in vivo [2, 5,
7] nor in the perfused kidney [28, 29]. In vivo an increment
in lithium excretion (dog) [2] and phosphaturia (rat) [4] was
observed. Changes of sodium—coupled transport (Pi co-
transport, H contratransport) were also observed on brush
border vesicles of ANF-treated rats [301. These findings are
compatible with a direct inhibition of proximal reabsorption by
ANF. However no specific effect was observed on rabbit
proximal tubules perfused in vitro [31]. In contrast, direct
micropuncture [5] as well as microcatheterization [6] and distal
blockade [7] studies suggested that ANF may affect a more
distal part of the nephron. From these studies it appears,
therefore, that both hemodynamics and tubular effects may
explain the natriuretic action of ANF. The possible site(s) of
this action of ANF along the nephron is not clear. Finally, it
remains possible that ANF triggers the secretion of a second
messenger within the kidney that leads to the spectacular
diuresis induced by this peptide.
In order to investigate this problem, we have studied in vitro
>.
_ 100
ANF, jsg/ml 0
16 1 1 1
.s13
Vanadate, mM 0 5 10 20 30 50 100
Ouabaine 0 1 2 3 4 5
Rat proximal tubules
Fig. 2. Dose response curve of the effect of ANF (•, 0.1-10 p.g/ml),
vanadate (z, 1-100 mM) or ouabain (LII, 4.5 mM) + vanadate on oxygen
uptake by proximal tubules of rat kidney. The effect of ouabain alone
(, 4.5 mM) is presented as well as the effect of the vehicle for ANF (,
acetic acid 2.5 mM).
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the effect of 101-126 ANF on the metabolism of various nephron
segments of the dog and rat kidney. Our study uses a novel
approach for the identification in vitro of the nephron site(s)
responsive to a diuretic molecule: by following an indirect index
of the cell ATP turnover, that is, 02 consumption, it is possible
to disclose a change in cell work induced by a change of
permeability of the cell membrane to sodium or chloride. The
lumen of these tubular fragments being open, the activity of
both the luminal and antiluminal sodium exchangers are indi-
rectly monitored. The use of defined proximal and distal seg-
ments of nephron allows to locate the site of the functional
effects of a diuretic along the nephron.
In this study, our approach has confirmed the metabolic
heterogeneity of proximal, thick ascending limbs and collecting
duct tubules. The preparation of thick ascending limbs in gram
quantities from the two kidneys of one dog is a development of
potential interest for biochemical and pharmacological studies
of this segment of the nephron. With this preparation, we have
confirmed that thick ascending limbs are exquisitely sensitive to
low concentration of furosemide while proximal tubules are
only slightly affected. This observation is in accord with the
distribution of receptors to furosemide along the nephron.
Furthermore it is demonstrated, as shown previously by Le
Bouffant, Hus-Citharel and Morel [32] and Chamberlin,
Lefurgey and Mandel [121, that the ATP turnover in these
epithelial cells is directly related to the membrane permeability
to sodium and chloride, that is, to the secondary sodium
transport by the Na-K-ATPase. The lack of response of prox-
imal tubular metabolism to amiloride or hydrochlorothiazide
confirms the predominant distal site of action of these mole-
cules and is in accord with other studies [331 where no effect of
amiloride could be demonstrated in proximal tubules. Unfortu-
nately, pure preparations of cortical distal tubules and cortical
collecting ducts are not available to us for the moment and the
effect of diuretics on the metabolism of these nephron segments
could not be studied.
No specific diuretic—like metabolic effect of ANF was ob-
served in all nephron segments studied. This suggests that the
ANF-induced natriuresis is not related to specific changes in
sodium/chloride permeability occurring in the cells of the
segments studied here. It cannot be ruled out, however, that
such effects could occur in nephron segments not studied by us
(distal cortical segments, cortical collecting ducts). Alterna-
tively, ANF may change the passive component(s) of sodium
reabsorption in vivo through hemodynamic changes, a process
not reproducible with tubular fragments in vitro. Finally, it
remains possible that ANF exerts its diuretic action through "a
second messenger" which would be produced or released by
intact organs in vivo or in vitro but not by tubules suspensions
[34] as already postulated by others [35].
The absence of metabolic effect of ANF on segments of
proximal tubules is in good accord with the absence of recep-
tors for ANF in this segment of the dog [36—38] or rat nephron
[39]. However, receptors to ANF have been described in
glomeruli [36—39], thick ascending limbs [36, 37] and papillary
collecting ducts [36, 37] of the dog kidney together with a
specific and rapid (minutes) post-receptor activation of a par-
ticulate guanylate cyclase activity [37, 38]. The present study
demonstrates that the activation of these receptors does not
induce diuretic—like metabolic changes in these structures and
therefore mediates undefined functional consequences for these
cells.
The absence of metabolic effects of ANF in the present study
contrasts with a previous report describing an ANF-induced
(atriopeptin 103-126) inhibition of respiration by isolated rat
kidney mitochondria attributed to a swelling of these structures
[40]. The physiological implications of this observation are
uncertain since we could not demonstrate such an effect with
intact tubules. It is possible that ANF does not reach or does
not affect mitochondria left in their natural tubular environ-
ment.
It should be noted also that we have observed no stimulation
of glucose production by proximal tubules under the influence
of ANFs (101-126, 103-126 and 105-126), even when short (3 to
12 mm) incubation times were used and when lactate was used
as a vehicle for ANF. These observations contrast with the
striking stimulation of gluconeogenesis elicited in rat tubules by
the 103-126 peptide (atriopeptin III), reported by Obara et al
[41]. In this latter report, the stimulation of gluconeogenesis
was especially marked in the presence of c'GMP in the incuba-
tion fluid of rat tubules. Since the preparation used by Obara et
al is contaminated by glomeruli, and since ANF elicited a
marked synthesis and release of c'GMP by these structures, it
was possible that the absence of glomeruli (and of ANF-induced
c'GMP) in our proximal tubules preparation could have pre-
vented the observation of a gluconeogenic effect requiring
simultaneously ANF and c'GMP. It should be recalled that
proximal tubules of rats and dogs lack both receptors for ANF
[36—39] and the particulate guanylate cyclase [37] responsible
for the c'GMP synthesis under the influence of ANF. We
checked, therefore, if the addition of c'GMP or 8-bromo c'GMP
together with these peptides could enhance glucose production
when lactate, malate or glutamine were used as substrate. No
effect was noted. Thus, we were not able to reproduce the very
impressive (eightfold) increment of glucose synthesis noted by
Obara et al [41]. The reason for this discrepancy remains
unclear.
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